Md. Code Ann., Health-Gen. § 13-3101
Definitions
Effective Jul 1, 2025Added by Acts 2013, c. 299, § 1, eff. Oct. 1, 2013. Amended by Acts 2015, c. 356, § 1, eff. Oct. 1, 2015; Acts 2017, c. 571, § 1, eff. June 1, 2017; Acts 2017, c. 572, § 1, eff. June 1, 2017; Acts 2022, c. 239, § 1, eff. July 1, 2022; Acts 2025, c. 698, § 1, eff. July 1, 2025; Acts 2025, c. 699, § 1, eff. July 1, 2025.State of Maryland
- (a) In this subtitle the following words have the meanings indicated.
- (b) “Pharmacist” has the meaning stated in § 12-101 of the Health Occupations Article.
- (c) “Private or public entity” means a health care provider, local health department, community-based organization, substance abuse treatment organization, or other person that addresses medical or social issues related to drug addiction.
- (d) “Program” means the Overdose Response Program.
- (e) “Standing order” means a written instruction for the prescribing and dispensing of an opioid overdose reversal drug approved by the federal Food and Drug Administration in accordance with § 13-3106 of this subtitle.
Added by Acts 2013, c. 299, § 1, eff. Oct. 1, 2013. Amended by Acts 2015, c. 356, § 1, eff. Oct. 1, 2015; Acts 2017, c. 571, § 1, eff. June 1, 2017; Acts 2017, c. 572, § 1, eff. June 1, 2017; Acts 2022, c. 239, § 1, eff. July 1, 2022; Acts 2025, c. 698, § 1, eff. July 1, 2025; Acts 2025, c. 699, § 1, eff. July 1, 2025.